Literature DB >> 10624302

Ear helix flap for reconstruction of total loss of the upper eyelid.

I Koshima1, K Urushibara, H Okuyama, T Moriguchi.   

Abstract

We present a patient with a recurrent carcinoma of the right upper eyelid who underwent resection of the subtotal upper eyelid resulting in a full-thickness defect. The eyelid was reconstructed with advanced conjunctival lining and an ascending helix chondrocutaneous flap from the right auricle. This flap was nourished with a reverse flow of the frontal branch of the superficial temporal vessels. A superficial temporal vein of the flap was anastomosed to the zygomaticofacial branch of the superficial temporal vein at the lateral canthal region to ensure adequate drainage. The flap survived without any congestion. An ascending helix flap is the best candidate for total loss of the upper eyelid.

Entities:  

Mesh:

Year:  1999        PMID: 10624302     DOI: 10.1054/bjps.1998.3055

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  4 in total

1.  Total upper eyelid reconstruction by single staged malar-cheek flap.

Authors:  Rajeev B Ahuja; Pallab Chatterjee; Gaurav K Gupta; Prabhat Shrivastava
Journal:  Indian J Plast Surg       Date:  2014-01

2.  Use of vascularised cartilage as an additional interposition in temporomandibular ankylosis surgery: Rationale, advantages and potential benefits.

Authors:  Mukund Jagannathan; Maksud Devale; Prashantha Kesari; Siddharth Karanth
Journal:  Indian J Plast Surg       Date:  2008-07

3.  Lower lid reconstruction utilizing auricular conchal chondral-perichondral tissue in patients with neoplastic lesions.

Authors:  Pier Camillo Parodi; Fabrizio Calligaris; Fabrizio De Biasio; Giovanna De Maglio; Flavia Miani; Marco Zeppieri
Journal:  Biomed Res Int       Date:  2013-06-20       Impact factor: 3.411

4.  Supermicrosurgery: History, Applications, Training and the Future.

Authors:  Ido Badash; Daniel J Gould; Ketan M Patel
Journal:  Front Surg       Date:  2018-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.